Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 132.20
+0.20 (0.15%)
Aug 3, 2026, 5:30 PM CET
Medacta Group Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Medacta Group stock has a consensus rating of "Buy" and an average price target of CHF 179.97. The average 1-year stock price forecast is 36.13% higher than the current stock price, while the lowest is CHF 149.15 (+12.82%) and the highest is CHF 198.70 (+50.30%).
Price Target: CHF 179.97 (+36.13%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medacta Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains CHF 151.00 → CHF 148.00 | Hold | Maintains | CHF 151.00 → CHF 148.00 | +11.95% | Jul 21, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains CHF 182.00 → CHF 185.00 | Buy | Maintains | CHF 182.00 → CHF 185.00 | +39.94% | Mar 19, 2026 |
Financial Forecast
Revenue This Year
764.46M
from 683.83M
Increased by 11.79%
Revenue Next Year
857.60M
from 764.46M
Increased by 12.18%
EPS This Year
5.20
from 4.33
Increased by 20.05%
EPS Next Year
5.96
from 5.20
Increased by 14.59%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.